2 - 4 October | Copenhagen, Denmark
ISSCR iPSC-derived cell therapies
Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, will gather pioneers at the forefront of ESC and iPSC-derived cell therapies-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionise the next generation of cell therapies
Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, will gather pioneers at the forefront of ESC and iPSC-derived cell therapies-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionise the next generation of cell therapies
We are sponsoring this event!
Come and visit our team at our stand to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.
Arrange a meeting